Page last updated: 2024-11-03

rabeprazole and Aging

rabeprazole has been researched along with Aging in 1 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.

Research Excerpts

ExcerptRelevanceReference
" The substance has an absolute bioavailability upon oral administration of approximately 52% which is robust against food intake or administration of antacids."2.41Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions. ( Fuhr, U; Jetter, A, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fuhr, U1
Jetter, A1

Reviews

1 review available for rabeprazole and Aging

ArticleYear
Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions.
    Die Pharmazie, 2002, Volume: 57, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aging; Anti-Ulcer Agents; Benzimidazoles; Biological

2002